During the first year, you will receive HER2 targeted therapy as an injection once every three weeks. These visits will also include an exam with your provider and a meeting with your research coordinator. At a few of these visits, you will have blood drawn and answer some questionnaires. Your heart function will be monitored every 3 months. After the first year, your follow-up visits will change to an exam with the provider once every 6 months.